Skip to main contentAll experts

DrMichael Haller

CHIEF & PROF

MD-PEDIATRICS

Orcid identifier0000-0002-2803-1824 (opens in a new tab)⁠
  • CHIEF & PROF
    MD-PEDIATRICS

GRANTS

  • GRANT
    PRISE-hATG: Personalized Response and Immunologic Surveillance of Endogenous CPeptide Preservation in New, Recent, and Established Onset T1D Treated with Human Anti-Thymocyte Globulin
    Sab Biotherapeutics1 Jul 2026 - 30 Jun 2030
    Active
  • GRANT
    TrialNet affiliates reimbursement FY27
    National Institute of Health Niddk1 Jun 2026 - 31 May 2027
    Active
  • GRANT
    Mechanisms of RNA Immunotherapy for type 1 diabetes prevention
    Pediatric Endocrine Society3 Apr 2026 - 30 Jun 2027
    Active
  • GRANT
    Data Coordinating Center for Type 1 Diabetes TrialNet
    National Institute of Health Niddk26 Nov 2025 - 31 May 2026
    Expired
  • GRANT
    A randomized, double-blind, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with recently diagnosed Stage 3 Type 1 Diabetes
    Sanofi Us Services17 Nov 2025 - 16 Nov 2030
    Active
  • GRANT
    Google.org Social Impact Funding: Google AI for Health Education in Diabetes
    Google.Org29 Oct 2025 - 31 Oct 2028
    Active
  • GRANT
    An Observational, Long-term Safety Study of TZIELD™ (teplizumab-mzwv) in Patients with Stage 2 Type 1 Diabetes
    Sanofi Us Services7 Oct 2025 - 6 Oct 2030
    Active
  • GRANT
    Precision administration of anti-thymocyte globulin with or without verapamil in adolescents and young adults with type 1 diabetes
    National Institute of Health Niddk18 Aug 2025 - 30 Jun 2030
    Active
  • GRANT
    GENESIS: next GENEration Sensor Life Study
    Medtronic Minimed4 Aug 2025 - 3 Aug 2030
    Active
  • GRANT
    A Non-Interventional Study of HLA-DRB1*04:01 Distribution in Adults With Recently Diagnosed Type 1 Diabetes (T1D)
    Gentibio24 Jul 2025 - 23 Jul 2030
    Active
  • GRANT
    Pediatric Endocrinology Fellowship
    Sanofi Us Services15 Jul 2025 - 14 Jul 2028
    Active
  • GRANT
    TrialNet affiliates reimbursement FY26
    National Institute of Health Niddk1 Jul 2025 - 31 May 2026
    Expired
  • GRANT
    Extension for Community Healthcare Outcomes (ECHO) Diabetes for Federally Qualified Health Centers (FQHC)
    American Diabetes Association25 Jun 2025 - 30 Jun 2028
    Active
  • GRANT
    Synergy Plus: Evaluation of Next Generation Sensors (NGS And Algorithm in Patients with Type 1 and Type 2 Diabetes Study
    Medtronic Inc19 May 2025 - 20 May 2025
    Expired
  • GRANT
    TrialNet affiliates reimbursement FY25
    National Institute of Health Niddk14 Jan 2025 - 30 Jun 2025
    Expired
  • GRANT
    Conceptualization of a Social Determinants of Mental and Behavioral Health (SDMBH) Screening Protocol in the Progression of Autoantibodies to Overt Type 1 Diabetes: An Exploratory Study to Advance Translation and Health Equity Using Technology
    National Institute of Health Niddk1 Oct 2024 - 31 Dec 2026
    Active
  • GRANT
    Implementation of Early Stage T1D Education and Support (ESTES)
    Helmsley Charitable Trust, Leona & Harry10 Apr 2024 - 30 Nov 2026
    Active
  • GRANT
    A 52-week randomized, double-blind, placebo-controlled, multi-center Phase 2b study with a 52-week blinded extension assessing safety and efficacy of frexalimab, a CD40Lantagonist monoclonal antibody, for preservation of pancreatic ß-cell function in adults and adolescents with newly diagnosed type 1 diabetes on insulin therapy
    Sanofi8 Apr 2024 - 7 Apr 2029
    Active
  • GRANT
    The T1D Financial Toolkit for Emerging Adults
    Helmsley Charitable Trust, Leona & Harry20 Feb 2024 - 31 Mar 2025
    Expired
  • GRANT
    TrialNet Clinic Agreement - Site #0001
    National Institute of Health Niddk11 Dec 2023 - 30 Jun 2024
    Expired
  • GRANT
    The TEDDY Data Coordinating Center
    National Institute of Health Niddk13 Oct 2023 - 31 Mar 2025
    Expired
  • GRANT
    Understanding T1D and Insulin-Requiring Diabetes in Federally Qualified Health Centers (FQHC): A National Needs Assessment
    Helmsley Charitable Trust, Leona & Harry21 Aug 2023 - 31 Jul 2026
    Expired
  • GRANT
    Project ECHO Teleclinics for Rural Providers
    Florida Department of Health1 Jul 2023 - 30 Jun 2024
    Expired
  • GRANT
    Georgia Center for Diabetes Translation Research Renewal - PILOT
    National Institute of Health Niddk26 Apr 2023 - 30 Jun 2024
    Expired
  • GRANT
    Immune Function and the Progression to Type 1 Diabetes
    National Institute of Health Niaid11 Apr 2023 - 31 May 2028
    Active